Aditxt, Inc. Increase (Decrease) in Prepaid Expense
Aditxt, Inc. (ADTX) reported Increase (Decrease) in Prepaid Expense of -$294.31 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-05-20
- Aditxt, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was -$294.31K, a 596.83% decline year-over-year.
- Aditxt, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was $554.75K.
- Aditxt, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Aditxt, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-06-30 was $0.00.
- Aditxt, Inc. increase (decrease) in prepaid expense for fiscal 2025 was $613.98K.
- Aditxt, Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$214.01K.
- Aditxt, Inc. increase (decrease) in prepaid expense for fiscal 2023 was -$279.48K, a 860.14% decline from fiscal 2022.
- Aditxt, Inc. increase (decrease) in prepaid expense for fiscal 2022 was $36.77K, a 88.02% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$294.31K 10-Q · filed 2026-05-20 | $260.44K derived: sum of 2 quarters · filed 2026-05-20 | $260.44K derived: sum of 3 quarters · filed 2026-05-20 | $260.44K derived: sum of 4 quarters · filed 2026-05-20 | |||
| 2025-12-31 | $554.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $554.75K derived: sum of 2 quarters · filed 2026-03-31 | $554.75K derived: sum of 3 quarters · filed 2026-03-31 | $613.98K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | $0.00 derived: sum of 2 quarters · filed 2025-11-18 | $59.24K 10-Q · filed 2025-11-18 | -$381.74K derived: sum of 4 quarters · filed 2026-05-20 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $59.24K 10-Q · filed 2025-08-14 | -$381.74K derived: sum of 3 quarters · filed 2026-05-20 | -$380.67K derived: sum of 4 quarters · filed 2026-05-20 | |||
| 2025-03-31 | $59.24K 10-Q · filed 2026-05-20 | -$381.74K derived: sum of 2 quarters · filed 2026-05-20 | -$380.67K derived: sum of 3 quarters · filed 2026-05-20 | -$394.27K derived: sum of 4 quarters · filed 2026-05-20 | |||
| 2024-12-31 | -$440.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$439.91K derived: sum of 2 quarters · filed 2026-03-31 | -$453.50K derived: sum of 3 quarters · filed 2026-03-31 | -$214.01K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $1.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | -$12.53K derived: sum of 2 quarters · filed 2025-11-18 | $226.97K 10-Q · filed 2025-11-18 | -$111.28K derived: sum of 4 quarters · filed 2025-11-18 | |||
| 2024-06-30 | -$13.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $225.90K 10-Q · filed 2025-08-14 | -$112.34K derived: sum of 3 quarters · filed 2025-08-14 | -$210.67K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $239.49K 10-Q · filed 2025-05-15 | -$98.75K derived: sum of 2 quarters · filed 2025-05-15 | -$197.07K derived: sum of 3 quarters · filed 2025-05-15 | -$91.52K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$338.24K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$436.56K derived: sum of 2 quarters · filed 2025-03-31 | -$331.01K derived: sum of 3 quarters · filed 2025-03-31 | -$279.48K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$98.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | $7.23K derived: sum of 2 quarters · filed 2024-11-18 | $58.76K 10-Q · filed 2024-11-18 | $76.67K derived: sum of 4 quarters · filed 2024-11-18 | |||
| 2023-06-30 | $105.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $157.09K 10-Q · filed 2024-08-19 | $174.99K derived: sum of 3 quarters · filed 2024-08-19 | $63.54K derived: sum of 4 quarters · filed 2024-08-19 | |||
| 2023-03-31 | $51.53K 10-Q · filed 2024-05-20 | $69.44K derived: sum of 2 quarters · filed 2024-05-20 | -$42.02K derived: sum of 3 quarters · filed 2024-05-20 | $13.46K derived: sum of 4 quarters · filed 2024-05-20 | |||
| 2022-12-31 | $17.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$93.55K derived: sum of 2 quarters · filed 2024-04-16 | -$38.07K derived: sum of 3 quarters · filed 2024-04-16 | $36.77K 10-K · filed 2024-04-16 | -$23.88K 10-K · filed 2023-04-17 | ||
| 2022-09-30 | -$111.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$55.98K derived: sum of 2 quarters · filed 2023-11-14 | $18.86K 10-Q · filed 2023-11-14 | $82.46K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $55.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $130.32K 10-Q · filed 2023-08-14 | $193.91K derived: sum of 3 quarters · filed 2023-08-14 | $237.73K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $74.84K 10-Q · filed 2023-05-15 | $138.44K derived: sum of 2 quarters · filed 2023-05-15 | $182.26K derived: sum of 3 quarters · filed 2023-05-15 | $148.78K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $63.59K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $107.42K derived: sum of 2 quarters · filed 2023-04-17 | $73.94K derived: sum of 3 quarters · filed 2023-04-17 | $306.95K 10-K · filed 2023-04-17 | $312.46K 10-K · filed 2022-03-31 | ||
| 2021-09-30 | $43.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $10.35K derived: sum of 2 quarters · filed 2022-11-14 | $243.36K 10-Q · filed 2022-11-14 | $268.43K 10-Q · filed 2021-11-15 | $152.69K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$33.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $199.54K 10-Q · filed 2022-08-15 | $384.71K 10-Q · filed 2021-08-12 | $108.87K derived: sum of 3 quarters · filed 2022-08-15 | $322.10K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $233.01K 10-Q · filed 2022-05-16 | $142.34K derived: sum of 2 quarters · filed 2022-05-16 | $355.57K derived: sum of 3 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$90.67K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $122.56K derived: sum of 2 quarters · filed 2022-03-31 | $147.64K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $213.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $238.31K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $25.08K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |